SSSarah Wordenskjold Stougaard

Sarah Wordenskjold Stougaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Wordenskjold Stougaard has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multi-centre generalisability of deep learning-based dose prediction for head and neck radiotherapy using DAHANCA real-world data

    by Camilla P. Nielsen, Margerie Huet-Dastarac, Kenneth Jensen, Carsten Brink, Bob Smulders, Anne I.S. Holm, Martin S. Nielsen, Patrik Sibolt, John A. Lee, Edmond Sterpin, et al.

  • Open Access

    Impact of GTV-CTV margin and other predictors on radiation-induced dysphagia in head and neck cancer patients from DAHANCA group

    by Sarah Wordenskjold Stougaard, Ruta Zukauskaite, Richard Röttger, Ebbe Laugaard Lorenzen, Maximilian Lukas Konrad, Simon Long Krogh, Camilla Panduro Nielsen, Jeanette Frieda Aviaya Sommer, Jørgen Johansen, Jesper Grau Eriksen, et al.

    Background and purpose: This multicentre, retrospective study aimed to develop a predictive model for radiation-induced dysphagia in head and neck cancer patients, focusing on the role of gross tumour volume (GTV) to high dose CTV (CTV1) margin size and dose-related factors. Unlike previous studies focused on peak or single time-point dysphagia, this study modelled symptom trajectories using repeated follow-up data for a more complete picture. Patient/material and methods: Between 2010 and 2015, 1,948 patients with pharyngeal or laryngeal squamous cell carcinoma received definitive intensity-modulated radiotherapy (IMRT) at three Danish centres. Data included physician-rated dysphagia (grade 0–4), tumour and treatment characteristics, and AI-based segmentations of organs at risk (OARs). Predictors included GTV-CTV1 margin size, mean doses to the oral cavity and pharyngeal constrictor muscles (PCM), GTV volume, chemotherapy, tumour site, fractionation, nimorazole, sex, smoking status, baseline dysphagia, and age. A logistic ordinal mixed-effects model was fitted with patient ID as random effect. Data were split into training (70%) and test (30%) sets. Model performance was assessed using calibration plots and area under the curve (AUC). Results: After excluding incomplete cases, 1,685 patients (7,829 visits) were analysed. GTV-CTV1 margin size was not significantly associated with dysphagia, although larger margins correlated with higher OAR doses. Higher doses to the lower PCM (odds ratio [OR] = 1.30 per 5 Gy) and oral cavity (OR = 1.32 per 5 Gy) increased risk. The model demonstrated good calibration and robust discrimination (AUC = 0.77–0.84). Interpretation: Radiation dose to the oral cavity and lower PCM were the strongest modifiable predictors of dysphagia risk. Margin size was not independently associated, possibly due to confounding by clinical judgement.


  • Open Access

    Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses

    by Christian Rønn Hansen, Anders S. Bertelsen, Irene Hazell, Sarah W Stougaard, Jørgen Johansen, Jens Overgaard, Jesper Grau Eriksen, Ruta Zukauskaite

    Background and purpose: Radiotherapy for head and neck cancer must balance tumour control with late toxicities such as dysphagia and xerostomia. Recent retrospective studies suggest that the margin from the gross tumour volume (GTV) to the high-dose clinical target volume (CTV1) may not be critical for local control, while larger irradiated volumes increase the risk of toxicity. The study quantifies potential reductions in dose to organs at risk (OARs) and predicted dysphagia risk when the standard 5 mm GTV-to-CTV1 margin is eliminated in oropharyngeal cancer. Patient/material and methods: Retrospectively 30 oropharyngeal cancer patients treated consecutively during 2023 according to the DAHANCA guidelines (5 mm GTV-to-CTV1 margin) were selected. For each patient, a standard plan and a modified experimental plan (CTV1 = GTV, and CTV2 reduced by 5 mm accordingly) were generated using Pinnacle3 Auto-Planning. All plans met the DAHANCA target coverage and OAR dose constraints. Dose-volume data for relevant OARs were extracted and compared in MATLAB. Normal tissue complication probability (NTCP) model for dysphagia was applied. Results: Margin elimination reduced high-dose CTV volumes by 70%, yielding significant dose reductions to multiple OARs. Mean doses to the upper/middle pharyngeal constrictors decreased by around 4–5 Gy (p < 0.001) and to the contralateral submandibular gland by ~5 Gy (p < 0.001). These dosimetric gains correspond to an estimated median ΔNTCP of 6.0% of late grade ≥ 2 dysphagia. Target coverage and conformity were maintained in all plans. Interpretation: Omitting the high-risk CTV margin can substantially reduce the dose to dysphagia-­associated OAR without compromising target coverage. This approach shows promise for improving patient-reported swallowing outcomes and warrants clinical evaluation.


  • Open Access

    AI-integrated Screening to Replace Double Reading of Mammograms: A Population-wide Accuracy and Feasibility Study

    by Mohammad T. Elhakim, Sarah W. Stougaard, Ole Graumann, Mads Nielsen, Oke Gerke, Lisbet B. Larsen, Benjamin S. B. Rasmussen

    "Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Mammography screening supported by deep learning-based artificial intelligence (AI) solutions can potentially reduce workload without compromising breast cancer detection accuracy, but the site of deployment in the workflow might be crucial. This retrospective study compared three simulated AI-integrated screening scenarios with standard double reading with arbitration in a sample of 249,402 mammograms from a representative screening population. A commercial AI system replaced the first reader (Scenario 1: Integrated AIfirst), the second reader (Scenario 2: Integrated AIsecond), or both readers for triaging of low- and high-risk cases (Integrated AItriage). AI threshold values were partly chosen based on previous validation and fixing screen-read volume reduction at approximately 50% across scenarios. Detection accuracy measures were calculated. Compared with standard double reading, Integrated AIfirst showed no evidence of a difference in accuracy metrics except for a higher arbitration rate (+0.99%; P < .001). Integrated AIsecond had lower sensitivity (-1.58%; P < 0.001), negative predictive value (NPV) (- 0.01%; P < .001) and recall rate (< 0.06%; P = 0.04), but a higher positive predictive value (PPV) (+0.03%; P < .001) and arbitration rate (+1.22%; P < .001). Integrated AItriage achieved higher sensitivity (+1.33%; P < .001), PPV (+0.36%; P = .03), and NPV (+0.01%; P < .001) but lower arbitration rate (-0.88%; P < .001). Replacing one or both readers with AI seems feasible, however, the site of application in the workflow can have clinically relevant effects on accuracy and workload. ©RSNA, 2024.